PubRank

Cost-effectiveness of percutaneous coronary intervention versus bypass surgery from a Dutch perspective.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 26552756)

Published in Heart on November 09, 2015

Authors

Ruben L Osnabrugge1, Elizabeth A Magnuson2, Patrick W Serruys3, Carlos M Campos4, Kaijun Wang2, David van Klaveren5, Vasim Farooq3, Mouin S Abdallah2, Haiyan Li2, Katherine A Vilain2, Ewout W Steyerberg5, Marie-Claude Morice6, Keith D Dawkins7, Friedrich W Mohr8, A Pieter Kappetein9, David J Cohen2, SYNTAX trial investigators

Author Affiliations

1: Department of Cardiovascular Research, Saint Luke's Mid America Heart Institute, University of Missouri-Kansas City, Kansas City, Missouri, USA Department of Cardio-Thoracic Surgery, Erasmus University Medical Centre, Rotterdam, The Netherlands.
2: Department of Cardiovascular Research, Saint Luke's Mid America Heart Institute, University of Missouri-Kansas City, Kansas City, Missouri, USA.
3: Department of Cardiology, Erasmus University Medical Centre, Rotterdam, The Netherlands.
4: Department of Cardiology, Erasmus University Medical Centre, Rotterdam, The Netherlands Heart Institute (InCor), University of São Paulo Medical School, Sao Paulo, Brazil.
5: Department of Public Health, Erasmus University Medical Centre, Rotterdam, The Netherlands.
6: Department of Interventional Cardiology, Institut Jacques Cartier, Massy, France.
7: Boston Scientific Corporation, Natick, Massachusetts, USA.
8: Department of Cardiac Surgery, Herzzentrum Universität Leipzig, Leipzig, Germany.
9: Department of Cardio-Thoracic Surgery, Erasmus University Medical Centre, Rotterdam, The Netherlands.

Associated clinical trials:

SYNTAX Study: TAXUS Drug-Eluting Stent Versus Coronary Artery Bypass Surgery for the Treatment of Narrowed Arteries (SYNTAX) | NCT00114972

Articles by these authors ⇆

The SYNTAX score revisited: a reassessment of the SYNTAX score reproducibility. Catheter Cardiovasc Interv (2010) 1.47

Differences in baseline characteristics, practice patterns and clinical outcomes in contemporary coronary artery bypass grafting in the United States and Europe: insights from the SYNTAX randomized trial and registry. Eur J Cardiothorac Surg (2014) 1.39

The impact of a second arterial graft on 5-year outcomes after coronary artery bypass grafting in the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery Trial and Registry. J Thorac Cardiovasc Surg (2015) 1.38

Incidence, Characteristics, Predictors, and Outcomes of Repeat Revascularization After Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting: The SYNTAX Trial at 5 Years. JACC Cardiovasc Interv (2016) 0.77

External validation and extension of a diagnostic model for obstructive coronary artery disease: a cross-sectional predictive evaluation in 4888 patients of the Austrian Coronary Artery disease Risk Determination In Innsbruck by diaGnostic ANgiography (CARDIIGAN) cohort. BMJ Open (2017) 0.75